SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5a55'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_2 (BETA-LACTAMASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	TYR A 393 PRO A 379 LEU A 397 THR A 424	None	1.38A	1i2wA-5a55A: undetectable	1i2wA-5a55A: 13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICU_D_NIOD223_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	PHE A 501 GLY A 469 SER A 826 THR A 829	None	1.21A	1icuC-5a55A: undetectable 1icuD-5a55A: undetectable	1icuC-5a55A: 11.01 1icuD-5a55A: 11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JQD_A_HSMA600_1 (HISTAMINE N-METHYLTRANSFERASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	GLU A 699 GLN A 770 VAL A 765 ASN A 696	None	1.35A	1jqdA-5a55A: 2.6	1jqdA-5a55A: 13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1K6C_B_MK1B902_2 (POL POLYPROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	GLY A 464 ALA A 465 ASP A 485 VAL A 542 VAL A 458	None	0.96A	1k6cB-5a55A: undetectable	1k6cB-5a55A: 6.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_I_BEZI518_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ILE A 731 GLY A 723 PRO A 702 ASN A 696	None	0.98A	1oniG-5a55A: undetectable 1oniI-5a55A: undetectable	1oniG-5a55A: 8.87 1oniI-5a55A: 8.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RI4_A_SAMA299_0 (MRNA CAPPING ENZYME)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	GLY A 656 GLY A 619 ILE A 671 ALA A 622 SER A 654	None	1.13A	1ri4A-5a55A: undetectable	1ri4A-5a55A: 14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_A_SAMA500_1 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	PHE A 367 ASN A 453 PHE A 347 SER A 449	None	1.10A	1rqpB-5a55A: undetectable	1rqpB-5a55A: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	PHE A 367 ASN A 453 PHE A 347 SER A 449	None	1.12A	1rqpC-5a55A: undetectable	1rqpC-5a55A: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_C_SAMC500_0 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	PHE A 367 ASN A 453 PHE A 347 SER A 449	None	1.12A	1rqpA-5a55A: undetectable	1rqpA-5a55A: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RX2_A_FOLA161_0 (DIHYDROFOLATE REDUCTASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	ALA A 615 LEU A 680 ILE A 667 LEU A 754 ILE A 693	None	0.97A	1rx2A-5a55A: undetectable	1rx2A-5a55A: 9.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RX7_A_FOLA161_0 (DIHYDROFOLATE REDUCTASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	ALA A 615 LEU A 680 ILE A 667 LEU A 754 ILE A 693	None	0.98A	1rx7A-5a55A: undetectable	1rx7A-5a55A: 9.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SN5_C_T3C601_2 (TRANSTHYRETIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	LYS A 495 ALA A 531 LEU A 529 VAL A 542	None	0.95A	1sn5C-5a55A: undetectable	1sn5C-5a55A: 7.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T7J_A_478A200_1 (POL POLYPROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	6 / 11	LEU A 360 GLY A 464 ALA A 465 ASP A 485 VAL A 542 VAL A 458	None	1.47A	1t7jA-5a55A: undetectable	1t7jA-5a55A: 6.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	ASN A 598 TRP A 512 GLN A 836	None	1.43A	1xoqA-5a55A: undetectable	1xoqA-5a55A: 15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XZX_X_T3X500_2 (THYROID HORMONE RECEPTOR BETA-1)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	PHE A1206 ARG A1210 ASN A1177	None	0.90A	1xzxX-5a55A: undetectable	1xzxX-5a55A: 13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YC2_A_NCAA506_0 (NAD-DEPENDENT DEACETYLASE 2)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	ALA A 580 ASN A 579 ILE A 591 ASP A 588	None CA A2419 (-3.0A) None CA A2419 (-2.2A)	1.00A	1yc2A-5a55A: undetectable	1yc2A-5a55A: 11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YC2_D_NCAD510_0 (NAD-DEPENDENT DEACETYLASE 2)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	ALA A 580 ASN A 579 ILE A 591 ASP A 588	None CA A2419 (-3.0A) None CA A2419 (-2.2A)	1.02A	1yc2D-5a55A: undetectable	1yc2D-5a55A: 11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2GVC_E_MMZE501_1 (MONOOXYGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	ASN A 517 TYR A 532 SER A 449	None	0.95A	2gvcE-5a55A: undetectable	2gvcE-5a55A: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H4J_A_NCAA1002_0 (NAD-DEPENDENT DEACETYLASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	ALA A 580 ASN A 579 ILE A 591 ASP A 588	None CA A2419 (-3.0A) None CA A2419 (-2.2A)	1.07A	2h4jA-5a55A: undetectable	2h4jA-5a55A: 12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_A_J01A1249_1 (CLAVALDEHYDE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	SER A 771 ILE A 733 ALA A 735 TYR A 664 ARG A 746	None	1.15A	2japA-5a55A: undetectable	2japA-5a55A: 12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_B_J01B1249_1 (CLAVALDEHYDE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	SER A 771 ILE A 733 ALA A 735 TYR A 664 ARG A 746	None	1.21A	2japB-5a55A: undetectable	2japB-5a55A: 12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_C_J01C1249_1 (CLAVALDEHYDE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	SER A 771 ILE A 733 ALA A 735 TYR A 664 ARG A 746	None	1.18A	2japC-5a55A: undetectable	2japC-5a55A: 12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_D_J01D1249_1 (CLAVALDEHYDE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	SER A 771 ILE A 733 ALA A 735 TYR A 664 ARG A 746	None	1.12A	2japD-5a55A: undetectable	2japD-5a55A: 12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QWX_A_ML1A233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ILE A 832 PHE A 501 PHE A 467 ILE A 824	None	0.81A	2qwxA-5a55A: undetectable 2qwxB-5a55A: 1.8	2qwxA-5a55A: 12.08 2qwxB-5a55A: 12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RLF_B_RIMB299_1 (MATRIX PROTEIN 2)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	LEU A 758 LEU A 691 ILE A 761 ARG A 792	None	1.04A	2rlfB-5a55A: undetectable 2rlfC-5a55A: undetectable	2rlfB-5a55A: 5.24 2rlfC-5a55A: 5.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V7U_A_SAMA1299_0 (5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	PHE A 367 ASN A 453 PHE A 347 SER A 449	None	1.14A	2v7uA-5a55A: undetectable	2v7uA-5a55A: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V7U_B_SAMB1299_1 (5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	PHE A 367 ASN A 453 PHE A 347 SER A 449	None	1.13A	2v7uB-5a55A: undetectable	2v7uB-5a55A: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XFS_A_J01A500_1 (ORF12)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	HIS A 657 GLY A 866 ALA A1157 LYS A1156	None	0.88A	2xfsA-5a55A: 1.9	2xfsA-5a55A: 18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XH9_A_J01A1436_1 (ORF12)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	HIS A 657 GLY A 866 ALA A1157 LYS A1156	None	0.90A	2xh9A-5a55A: 2.5	2xh9A-5a55A: 18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZBU_D_ADND504_1 (UNCHARACTERIZED CONSERVED PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	PHE A 367 ASN A 453 PHE A 347	None	0.60A	2zbuD-5a55A: undetectable	2zbuD-5a55A: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZUH_A_CAMA422_0 (CAMPHOR 5-MONOOXYGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	THR A1211 LEU A1108 VAL A1191 VAL A1142	None	1.01A	2zuhA-5a55A: undetectable	2zuhA-5a55A: 17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CLB_C_TMQC613_1 (DHFR-TS)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	ALA A 615 ILE A 671 ILE A 667 LEU A 754 ILE A 693	None	1.02A	3clbC-5a55A: undetectable	3clbC-5a55A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DCM_X_SAMX5452_0 (UNCHARACTERIZED PROTEIN TM_1570)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 11	ALA A 531 GLY A 500 SER A 457 VAL A 456 ALA A 454	None	0.93A	3dcmX-5a55A: undetectable	3dcmX-5a55A: 10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B304_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	ASN A1147 THR A1134 SER A1132 SER A1103	None	1.46A	3hlwB-5a55A: undetectable	3hlwB-5a55A: 13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_A_SAMA301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	SER A 860 ASP A 813 ASP A 843	None	0.81A	3iv6A-5a55A: undetectable	3iv6A-5a55A: 12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_C_SAMC301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	SER A 860 ASP A 813 ASP A 843	None	0.81A	3iv6C-5a55A: undetectable	3iv6C-5a55A: 12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K13_A_THHA642_1 (5-METHYLTETRAHYDROFO LATE-HOMOCYSTEINE METHYLTRANSFERASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	ASN A 874 ASP A1013 ARG A1094	None	0.91A	3k13A-5a55A: 5.0	3k13A-5a55A: 14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LSF_H_PZIH800_0 (GLUTAMATE RECEPTOR 2)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	TYR A 847 SER A 860 LEU A 814 ASP A 813	None	1.09A	3lsfH-5a55A: undetectable	3lsfH-5a55A: 13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBR_A_ASDA129_1 (STEROID DELTA-ISOMERASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	SER A 449 PHE A 347 VAL A 410 PRO A 348 PHE A 421	None	1.50A	3nbrA-5a55A: 1.9	3nbrA-5a55A: 8.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QJ7_A_SPMA264_1 (THYMIDYLATE SYNTHASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ARG A1269 ALA A1322 LEU A1354 ASP A1325	None	0.82A	3qj7A-5a55A: undetectable 3qj7D-5a55A: undetectable	3qj7A-5a55A: 13.88 3qj7D-5a55A: 13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUE_C_SUEC1201_2 (NS3 PROTEASE, NS4A PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	PHE A 618 ILE A 693 LEU A 649 LYS A 650	None	1.30A	3sueC-5a55A: undetectable	3sueC-5a55A: 10.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_A_MIYA2001_1 (TETX2 PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 11	GLN A 729 GLY A 723 PRO A 702 PHE A 707 GLY A 660	None	1.32A	3v3nA-5a55A: undetectable	3v3nA-5a55A: 16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_B_W9TB501_1 (HEMOLYTIC LECTIN CEL-III)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	ASP A 585 GLY A 589 TRP A 586 ASP A 468	CA A2419 ( 4.7A) None None None	1.30A	3w9tB-5a55A: undetectable	3w9tB-5a55A: 17.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_G_W9TG501_1 (HEMOLYTIC LECTIN CEL-III)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 4	ASP A 585 GLY A 589 TRP A 586 ASP A 468	CA A2419 ( 4.7A) None None None	1.29A	3w9tG-5a55A: 0.0	3w9tG-5a55A: 17.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A81_A_DXCA1161_0 (MAJOR POLLEN ALLERGEN BET V 1-A)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	ILE A1209 ASP A1061 ILE A1083 VAL A1084 LEU A1104	None	1.08A	4a81A-5a55A: undetectable	4a81A-5a55A: 8.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DA7_A_AC2A301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 10	MET A 490 ALA A 539 VAL A 536 GLU A 319 VAL A 364	None	1.26A	4da7A-5a55A: undetectable	4da7A-5a55A: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEU_B_KANB301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.19A	4feuB-5a55A: undetectable	4feuB-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEU_F_KANF301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.20A	4feuF-5a55A: undetectable	4feuF-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEV_D_KAND301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.21A	4fevD-5a55A: undetectable	4fevD-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEV_F_KANF301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.19A	4fevF-5a55A: undetectable	4fevF-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEW_D_KAND301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.21A	4fewD-5a55A: undetectable	4fewD-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEW_F_KANF301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.20A	4fewF-5a55A: undetectable	4fewF-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEX_B_KANB301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.21A	4fexB-5a55A: undetectable	4fexB-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_B_CQAB302_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	SER A1149 GLU A1198 GLY A1097 LYS A1080	None	1.04A	4fgzA-5a55A: undetectable 4fgzB-5a55A: undetectable	4fgzA-5a55A: 13.39 4fgzB-5a55A: 13.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4G0V_D_MIXD101_1 (DNA TOPOISOMERASE 2-BETA)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	ARG A 670 GLY A 668 ASN A 663 GLN A 623	None	1.22A	4g0vB-5a55A: undetectable	4g0vB-5a55A: 23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_B_KANB301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.20A	4gkhB-5a55A: undetectable	4gkhB-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_D_KAND301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.19A	4gkhD-5a55A: undetectable	4gkhD-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_G_KANG301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.20A	4gkhG-5a55A: undetectable	4gkhG-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_J_KANJ301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.25A	4gkhJ-5a55A: undetectable	4gkhJ-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKI_A_KANA301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.19A	4gkiA-5a55A: undetectable	4gkiA-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKI_C_KANC301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASP A1207 ASP A1013 ASN A1090 ASP A1091	CA A2422 (-2.2A) None CA A2422 (-3.2A) None	1.18A	4gkiC-5a55A: undetectable	4gkiC-5a55A: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_F_CAMF502_0 (CAMPHOR 5-MONOOXYGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 4	TYR A1328 THR A1257 VAL A1249 ILE A1383	None	1.35A	4jx1F-5a55A: undetectable	4jx1F-5a55A: 17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K7A_A_MXDA1002_1 (ANDROGEN RECEPTOR)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	GLU A1261 TRP A1284 LYS A 705	None	1.24A	4k7aA-5a55A: undetectable	4k7aA-5a55A: 11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L4A_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	THR A1211 LEU A1108 VAL A1191 VAL A1142	None	1.00A	4l4aA-5a55A: undetectable	4l4aA-5a55A: 17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N6P_A_JMSA713_1 (LACTOTRANSFERRIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 4	HIS A 429 ALA A 406 VAL A 427 GLU A 552	None	1.28A	4n6pA-5a55A: undetectable	4n6pA-5a55A: 14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QOG_A_ML1A302_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ILE A 832 PHE A 501 PHE A 467 ILE A 824	None	0.85A	4qogA-5a55A: 2.1 4qogB-5a55A: 2.2	4qogA-5a55A: 12.08 4qogB-5a55A: 12.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QYQ_A_3CJA607_1 (LACTOPEROXIDASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	GLN A 836 HIS A 835 ARG A 594	None	1.20A	4qyqA-5a55A: undetectable	4qyqA-5a55A: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QYQ_B_3CJB607_1 (LACTOPEROXIDASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	GLN A 836 HIS A 835 ARG A 594	None	1.18A	4qyqB-5a55A: undetectable	4qyqB-5a55A: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RUJ_A_VDXA501_1 (VITAMIN D3 RECEPTOR A)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	TYR A 803 VAL A 511 ARG A 528 SER A 515 TRP A 549	None	1.27A	4rujA-5a55A: undetectable	4rujA-5a55A: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WCX_C_SAMC503_0 (BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	GLY A1200 GLU A1202 LEU A1093 LEU A1069 ALA A1078	EDO A2423 ( 3.7A) None None None None	1.25A	4wcxC-5a55A: 4.2	4wcxC-5a55A: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y03_A_SALA801_1 (PROTEIN POLYBROMO-1)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	ILE A 377 MET A 408 ALA A 406 ILE A 404	None	0.77A	4y03A-5a55A: undetectable	4y03A-5a55A: 7.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	ASN A1048 SER A1066 TRP A1053 TYR A1060	None	1.27A	5amiB-5a55A: undetectable	5amiB-5a55A: 7.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AOX_C_ACTC1001_0 (ALU JO CONSENSUS RNA SIGNAL RECOGNITION PARTICLE 14 KDA PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	TYR A 497 THR A 527 THR A 471	None	0.82A	5aoxB-5a55A: 0.8	5aoxB-5a55A: 6.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AOX_F_ACTF1001_0 (ALU JO CONSENSUS RNA SIGNAL RECOGNITION PARTICLE 14 KDA PROTEIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	TYR A 497 THR A 527 THR A 471	None	0.83A	5aoxE-5a55A: undetectable	5aoxE-5a55A: 6.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	VAL A 350 TYR A 353 VAL A 511 HIS A 545	None	1.01A	5eclA-5a55A: undetectable	5eclA-5a55A: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESH_A_1YNA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	ALA A1081 LEU A1093 TYR A 873 GLY A1015 THR A1017	None	1.23A	5eshA-5a55A: undetectable	5eshA-5a55A: 18.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESM_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	TYR A1266 PHE A1402 GLY A 730 LEU A 712	None	0.98A	5esmA-5a55A: undetectable	5esmA-5a55A: 18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_B_X6XB203_1 (GALNAC/GAL-SPECIFIC LECTIN)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 9	TYR A 652 GLY A 651 GLY A 656 HIS A 661 ASP A 658	None	1.46A	5f8yB-5a55A: undetectable	5f8yB-5a55A: 8.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HQA_A_ACRA705_2 (ALPHA-GLUCOSIDASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	TRP A1380 PHE A1337 HIS A1352 THR A1257	None	1.40A	5hqaA-5a55A: 9.1	5hqaA-5a55A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HQA_A_ACRA705_2 (ALPHA-GLUCOSIDASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	TRP A1380 PHE A1337 HIS A1352 THR A1288	None	1.35A	5hqaA-5a55A: 9.1	5hqaA-5a55A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ERYA404_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 6	GLY A 619 ASP A 764 ILE A 693 TYR A 701	None	0.96A	5iwuA-5a55A: undetectable	5iwuA-5a55A: 14.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JMN_A_FUAA1101_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	ILE A 786 ILE A 693 HIS A 694 VAL A 695	None	0.92A	5jmnA-5a55A: undetectable	5jmnA-5a55A: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M66_D_ADND502_2 (ADENOSYLHOMOCYSTEINA SE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	THR A1257 THR A1301 LEU A1413	None	0.63A	5m66D-5a55A: undetectable	5m66D-5a55A: 17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NNW_D_GCSD302_1 (25 KDA PROTEIN ELICITOR)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	GLY A 644 ASP A 970 HIS A 892 ASP A 608	None	0.95A	5nnwD-5a55A: undetectable	5nnwD-5a55A: 5.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NO9_D_95ZD302_1 (25 KDA PROTEIN ELICITOR)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	GLY A 644 ASP A 970 HIS A 892 ASP A 608	None	0.99A	5no9D-5a55A: undetectable	5no9D-5a55A: 5.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_A_CUA602_0 (THIOCYANATE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	LYS A 650 HIS A 657 HIS A 694	None	1.16A	5oexA-5a55A: 2.1	5oexA-5a55A: 18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_B_CUB602_0 (THIOCYANATE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	LYS A 650 HIS A 657 HIS A 694	None	1.15A	5oexB-5a55A: 2.2	5oexB-5a55A: 18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_C_CUC603_0 (THIOCYANATE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	LYS A 650 HIS A 657 HIS A 694	None	1.15A	5oexC-5a55A: 2.2	5oexC-5a55A: 18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_D_CUD603_0 (THIOCYANATE DEHYDROGENASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	LYS A 650 HIS A 657 HIS A 694	None	1.13A	5oexD-5a55A: 2.5	5oexD-5a55A: 18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_E_CVIE301_1 (REGULATORY PROTEIN TETR)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 7	GLY A 842 TYR A 963 ASP A 884 ASP A 813	None	1.09A	5vlmE-5a55A: undetectable	5vlmE-5a55A: 11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIQ_B_HFGB1002_0 (PROLYL-TRNA SYNTHETASE (PRORS))	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 12	LEU A1297 PHE A1244 GLU A1350 HIS A1352 PHE A1318	None	1.41A	5xiqB-5a55A: undetectable	5xiqB-5a55A: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_A_8LXA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	3 / 3	SER A 911 HIS A 477 TYR A 819	None	0.90A	5y2tA-5a55A: undetectable	5y2tA-5a55A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C71_B_NCTB501_1 (AMINE OXIDASE)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 8	TYR A1158 GLU A1208 THR A1168 ASN A1177	None	1.21A	6c71B-5a55A: undetectable	6c71B-5a55A: 5.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EBP_A_DAHA123_0 (RIBONUCLEOSIDE-DIPHO SPHATE REDUCTASE, BETA SUBUNIT)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	5 / 9	LEU A1195 THR A1194 ILE A1074 PHE A1206 ILE A1095	None	1.32A	6ebpA-5a55A: undetectable	6ebpA-5a55A: 8.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FI4_B_DVAB8_0 (14-3-3 PROTEIN SIGMA PRO-SEP-LEU-PRO-DVA)	5a55	ENDO-ALPHA-N-ACETYLG ALACTOSAMINIDASE (Streptococcus pneumoniae)	4 / 5	SER A1103 VAL A1102 LYS A1101 ASN A1098	None	1.43A	6fi4A-5a55A: undetectable 6fi4B-5a55A: undetectable	6fi4A-5a55A: 12.71 6fi4B-5a55A: 0.86

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1I2W_A_CFXA1300_2","BETA-LACTAMASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TYR A 393;PRO A 379;LEU A 397;THR A 424","None","1.38A","1i2wA-5a55A:undetectable","1i2wA-5a55A:13.90"],["1ICU_D_NIOD223_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 501;GLY A 469;SER A 826;THR A 829","None","1.21A","1icuC-5a55A:undetectable;1icuD-5a55A:undetectable","1icuC-5a55A:11.01;1icuD-5a55A:11.01"],["1JQD_A_HSMA600_1","HISTAMINE N-METHYLTRANSFERASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"GLU A 699;GLN A 770;VAL A 765;ASN A 696","None","1.35A","1jqdA-5a55A:2.6","1jqdA-5a55A:13.22"],["1K6C_B_MK1B902_2","POL POLYPROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"GLY A 464;ALA A 465;ASP A 485;VAL A 542;VAL A 458","None","0.96A","1k6cB-5a55A:undetectable","1k6cB-5a55A:6.15"],["1ONI_I_BEZI518_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ILE A 731;GLY A 723;PRO A 702;ASN A 696","None","0.98A","1oniG-5a55A:undetectable;1oniI-5a55A:undetectable","1oniG-5a55A:8.87;1oniI-5a55A:8.87"],["1RI4_A_SAMA299_0","MRNA CAPPING ENZYME","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"GLY A 656;GLY A 619;ILE A 671;ALA A 622;SER A 654","None","1.13A","1ri4A-5a55A:undetectable","1ri4A-5a55A:14.75"],["1RQP_A_SAMA500_1","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 367;ASN A 453;PHE A 347;SER A 449","None","1.10A","1rqpB-5a55A:undetectable","1rqpB-5a55A:12.93"],["1RQP_B_SAMB500_1","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 367;ASN A 453;PHE A 347;SER A 449","None","1.12A","1rqpC-5a55A:undetectable","1rqpC-5a55A:12.93"],["1RQP_C_SAMC500_0","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 367;ASN A 453;PHE A 347;SER A 449","None","1.12A","1rqpA-5a55A:undetectable","1rqpA-5a55A:12.93"],["1RX2_A_FOLA161_0","DIHYDROFOLATE REDUCTASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ALA A 615;LEU A 680;ILE A 667;LEU A 754;ILE A 693","None","0.97A","1rx2A-5a55A:undetectable","1rx2A-5a55A:9.65"],["1RX7_A_FOLA161_0","DIHYDROFOLATE REDUCTASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ALA A 615;LEU A 680;ILE A 667;LEU A 754;ILE A 693","None","0.98A","1rx7A-5a55A:undetectable","1rx7A-5a55A:9.65"],["1SN5_C_T3C601_2","TRANSTHYRETIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"LYS A 495;ALA A 531;LEU A 529;VAL A 542","None","0.95A","1sn5C-5a55A:undetectable","1sn5C-5a55A:7.99"],["1T7J_A_478A200_1","POL POLYPROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",6,"LEU A 360;GLY A 464;ALA A 465;ASP A 485;VAL A 542;VAL A 458","None","1.47A","1t7jA-5a55A:undetectable","1t7jA-5a55A:6.15"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"ASN A 598;TRP A 512;GLN A 836","None","1.43A","1xoqA-5a55A:undetectable","1xoqA-5a55A:15.28"],["1XZX_X_T3X500_2","THYROID HORMONE RECEPTOR BETA-1","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"PHE A1206;ARG A1210;ASN A1177","None","0.90A","1xzxX-5a55A:undetectable","1xzxX-5a55A:13.06"],["1YC2_A_NCAA506_0","NAD-DEPENDENT DEACETYLASE 2","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ALA A 580;ASN A 579;ILE A 591;ASP A 588","None; CA A2419 (-3.0A);None; CA A2419 (-2.2A)","1.00A","1yc2A-5a55A:undetectable","1yc2A-5a55A:11.52"],["1YC2_D_NCAD510_0","NAD-DEPENDENT DEACETYLASE 2","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ALA A 580;ASN A 579;ILE A 591;ASP A 588","None; CA A2419 (-3.0A);None; CA A2419 (-2.2A)","1.02A","1yc2D-5a55A:undetectable","1yc2D-5a55A:11.52"],["2GVC_E_MMZE501_1","MONOOXYGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"ASN A 517;TYR A 532;SER A 449","None","0.95A","2gvcE-5a55A:undetectable","2gvcE-5a55A:17.42"],["2H4J_A_NCAA1002_0","NAD-DEPENDENT DEACETYLASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ALA A 580;ASN A 579;ILE A 591;ASP A 588","None; CA A2419 (-3.0A);None; CA A2419 (-2.2A)","1.07A","2h4jA-5a55A:undetectable","2h4jA-5a55A:12.67"],["2JAP_A_J01A1249_1","CLAVALDEHYDE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"SER A 771;ILE A 733;ALA A 735;TYR A 664;ARG A 746","None","1.15A","2japA-5a55A:undetectable","2japA-5a55A:12.72"],["2JAP_B_J01B1249_1","CLAVALDEHYDE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"SER A 771;ILE A 733;ALA A 735;TYR A 664;ARG A 746","None","1.21A","2japB-5a55A:undetectable","2japB-5a55A:12.72"],["2JAP_C_J01C1249_1","CLAVALDEHYDE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"SER A 771;ILE A 733;ALA A 735;TYR A 664;ARG A 746","None","1.18A","2japC-5a55A:undetectable","2japC-5a55A:12.72"],["2JAP_D_J01D1249_1","CLAVALDEHYDE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"SER A 771;ILE A 733;ALA A 735;TYR A 664;ARG A 746","None","1.12A","2japD-5a55A:undetectable","2japD-5a55A:12.72"],["2QWX_A_ML1A233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ILE A 832;PHE A 501;PHE A 467;ILE A 824","None","0.81A","2qwxA-5a55A:undetectable;2qwxB-5a55A:1.8","2qwxA-5a55A:12.08;2qwxB-5a55A:12.08"],["2RLF_B_RIMB299_1","MATRIX PROTEIN 2;MATRIX PROTEIN 2","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"LEU A 758;LEU A 691;ILE A 761;ARG A 792","None","1.04A","2rlfB-5a55A:undetectable;2rlfC-5a55A:undetectable","2rlfB-5a55A:5.24;2rlfC-5a55A:5.24"],["2V7U_A_SAMA1299_0","5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 367;ASN A 453;PHE A 347;SER A 449","None","1.14A","2v7uA-5a55A:undetectable","2v7uA-5a55A:12.93"],["2V7U_B_SAMB1299_1","5'-FLUORO-5'-DEOXY ADENOSINE SYNTHETASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 367;ASN A 453;PHE A 347;SER A 449","None","1.13A","2v7uB-5a55A:undetectable","2v7uB-5a55A:12.93"],["2XFS_A_J01A500_1","ORF12","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"HIS A 657;GLY A 866;ALA A1157;LYS A1156","None","0.88A","2xfsA-5a55A:1.9","2xfsA-5a55A:18.00"],["2XH9_A_J01A1436_1","ORF12","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"HIS A 657;GLY A 866;ALA A1157;LYS A1156","None","0.90A","2xh9A-5a55A:2.5","2xh9A-5a55A:18.00"],["2ZBU_D_ADND504_1","UNCHARACTERIZED CONSERVED PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"PHE A 367;ASN A 453;PHE A 347","None","0.60A","2zbuD-5a55A:undetectable","2zbuD-5a55A:13.10"],["2ZUH_A_CAMA422_0","CAMPHOR 5-MONOOXYGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"THR A1211;LEU A1108;VAL A1191;VAL A1142","None","1.01A","2zuhA-5a55A:undetectable","2zuhA-5a55A:17.03"],["3CLB_C_TMQC613_1","DHFR-TS","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ALA A 615;ILE A 671;ILE A 667;LEU A 754;ILE A 693","None","1.02A","3clbC-5a55A:undetectable","3clbC-5a55A:18.62"],["3DCM_X_SAMX5452_0","UNCHARACTERIZED PROTEIN TM_1570","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ALA A 531;GLY A 500;SER A 457;VAL A 456;ALA A 454","None","0.93A","3dcmX-5a55A:undetectable","3dcmX-5a55A:10.71"],["3HLW_B_CE3B304_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASN A1147;THR A1134;SER A1132;SER A1103","None","1.46A","3hlwB-5a55A:undetectable","3hlwB-5a55A:13.58"],["3IV6_A_SAMA301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"SER A 860;ASP A 813;ASP A 843","None","0.81A","3iv6A-5a55A:undetectable","3iv6A-5a55A:12.95"],["3IV6_C_SAMC301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"SER A 860;ASP A 813;ASP A 843","None","0.81A","3iv6C-5a55A:undetectable","3iv6C-5a55A:12.95"],["3K13_A_THHA642_1","5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE METHYLTRANSFERASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"ASN A 874;ASP A1013;ARG A1094","None","0.91A","3k13A-5a55A:5.0","3k13A-5a55A:14.38"],["3LSF_H_PZIH800_0","GLUTAMATE RECEPTOR 2","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TYR A 847;SER A 860;LEU A 814;ASP A 813","None","1.09A","3lsfH-5a55A:undetectable","3lsfH-5a55A:13.01"],["3NBR_A_ASDA129_1","STEROID DELTA-ISOMERASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"SER A 449;PHE A 347;VAL A 410;PRO A 348;PHE A 421","None","1.50A","3nbrA-5a55A:1.9","3nbrA-5a55A:8.49"],["3QJ7_A_SPMA264_1","THYMIDYLATE SYNTHASE;THYMIDYLATE SYNTHASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ARG A1269;ALA A1322;LEU A1354;ASP A1325","None","0.82A","3qj7A-5a55A:undetectable;3qj7D-5a55A:undetectable","3qj7A-5a55A:13.88;3qj7D-5a55A:13.88"],["3SUE_C_SUEC1201_2","NS3 PROTEASE, NS4A PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"PHE A 618;ILE A 693;LEU A 649;LYS A 650","None","1.30A","3sueC-5a55A:undetectable","3sueC-5a55A:10.25"],["3V3N_A_MIYA2001_1","TETX2 PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"GLN A 729;GLY A 723;PRO A 702;PHE A 707;GLY A 660","None","1.32A","3v3nA-5a55A:undetectable","3v3nA-5a55A:16.10"],["3W9T_B_W9TB501_1","HEMOLYTIC LECTIN CEL-III","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A 585;GLY A 589;TRP A 586;ASP A 468"," CA A2419 ( 4.7A);None;None;None","1.30A","3w9tB-5a55A:undetectable","3w9tB-5a55A:17.44"],["3W9T_G_W9TG501_1","HEMOLYTIC LECTIN CEL-III","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A 585;GLY A 589;TRP A 586;ASP A 468"," CA A2419 ( 4.7A);None;None;None","1.29A","3w9tG-5a55A:0.0","3w9tG-5a55A:17.44"],["4A81_A_DXCA1161_0","MAJOR POLLEN ALLERGEN BET V 1-A","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ILE A1209;ASP A1061;ILE A1083;VAL A1084;LEU A1104","None","1.08A","4a81A-5a55A:undetectable","4a81A-5a55A:8.87"],["4DA7_A_AC2A301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"MET A 490;ALA A 539;VAL A 536;GLU A 319;VAL A 364","None","1.26A","4da7A-5a55A:undetectable","4da7A-5a55A:12.37"],["4FEU_B_KANB301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.19A","4feuB-5a55A:undetectable","4feuB-5a55A:12.89"],["4FEU_F_KANF301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.20A","4feuF-5a55A:undetectable","4feuF-5a55A:12.89"],["4FEV_D_KAND301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.21A","4fevD-5a55A:undetectable","4fevD-5a55A:12.89"],["4FEV_F_KANF301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.19A","4fevF-5a55A:undetectable","4fevF-5a55A:12.89"],["4FEW_D_KAND301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.21A","4fewD-5a55A:undetectable","4fewD-5a55A:12.89"],["4FEW_F_KANF301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.20A","4fewF-5a55A:undetectable","4fewF-5a55A:12.89"],["4FEX_B_KANB301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.21A","4fexB-5a55A:undetectable","4fexB-5a55A:12.89"],["4FGZ_B_CQAB302_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"SER A1149;GLU A1198;GLY A1097;LYS A1080","None","1.04A","4fgzA-5a55A:undetectable;4fgzB-5a55A:undetectable","4fgzA-5a55A:13.39;4fgzB-5a55A:13.39"],["4G0V_D_MIXD101_1","DNA TOPOISOMERASE 2-BETA","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ARG A 670;GLY A 668;ASN A 663;GLN A 623","None","1.22A","4g0vB-5a55A:undetectable","4g0vB-5a55A:23.03"],["4GKH_B_KANB301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.20A","4gkhB-5a55A:undetectable","4gkhB-5a55A:12.89"],["4GKH_D_KAND301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.19A","4gkhD-5a55A:undetectable","4gkhD-5a55A:12.89"],["4GKH_G_KANG301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.20A","4gkhG-5a55A:undetectable","4gkhG-5a55A:12.89"],["4GKH_J_KANJ301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.25A","4gkhJ-5a55A:undetectable","4gkhJ-5a55A:12.89"],["4GKI_A_KANA301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.19A","4gkiA-5a55A:undetectable","4gkiA-5a55A:12.89"],["4GKI_C_KANC301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASP A1207;ASP A1013;ASN A1090;ASP A1091"," CA A2422 (-2.2A);None; CA A2422 (-3.2A);None","1.18A","4gkiC-5a55A:undetectable","4gkiC-5a55A:12.89"],["4JX1_F_CAMF502_0","CAMPHOR 5-MONOOXYGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TYR A1328;THR A1257;VAL A1249;ILE A1383","None","1.35A","4jx1F-5a55A:undetectable","4jx1F-5a55A:17.72"],["4K7A_A_MXDA1002_1","ANDROGEN RECEPTOR","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"GLU A1261;TRP A1284;LYS A 705","None","1.24A","4k7aA-5a55A:undetectable","4k7aA-5a55A:11.38"],["4L4A_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"THR A1211;LEU A1108;VAL A1191;VAL A1142","None","1.00A","4l4aA-5a55A:undetectable","4l4aA-5a55A:17.52"],["4N6P_A_JMSA713_1","LACTOTRANSFERRIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"HIS A 429;ALA A 406;VAL A 427;GLU A 552","None","1.28A","4n6pA-5a55A:undetectable","4n6pA-5a55A:14.48"],["4QOG_A_ML1A302_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ILE A 832;PHE A 501;PHE A 467;ILE A 824","None","0.85A","4qogA-5a55A:2.1;4qogB-5a55A:2.2","4qogA-5a55A:12.08;4qogB-5a55A:12.08"],["4QYQ_A_3CJA607_1","LACTOPEROXIDASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"GLN A 836;HIS A 835;ARG A 594","None","1.20A","4qyqA-5a55A:undetectable","4qyqA-5a55A:20.69"],["4QYQ_B_3CJB607_1","LACTOPEROXIDASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"GLN A 836;HIS A 835;ARG A 594","None","1.18A","4qyqB-5a55A:undetectable","4qyqB-5a55A:20.69"],["4RUJ_A_VDXA501_1","VITAMIN D3 RECEPTOR A","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"TYR A 803;VAL A 511;ARG A 528;SER A 515;TRP A 549","None","1.27A","4rujA-5a55A:undetectable","4rujA-5a55A:13.41"],["4WCX_C_SAMC503_0","BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"GLY A1200;GLU A1202;LEU A1093;LEU A1069;ALA A1078","EDO A2423 ( 3.7A);None;None;None;None","1.25A","4wcxC-5a55A:4.2","4wcxC-5a55A:18.37"],["4Y03_A_SALA801_1","PROTEIN POLYBROMO-1","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ILE A 377;MET A 408;ALA A 406;ILE A 404","None","0.77A","4y03A-5a55A:undetectable","4y03A-5a55A:7.84"],["5AMI_B_EF2B151_1","CEREBLON ISOFORM 4","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ASN A1048;SER A1066;TRP A1053;TYR A1060","None","1.27A","5amiB-5a55A:undetectable","5amiB-5a55A:7.39"],["5AOX_C_ACTC1001_0","ALU JO CONSENSUS RNA;SIGNAL RECOGNITION PARTICLE 14 KDA PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"TYR A 497;THR A 527;THR A 471","None","0.82A","5aoxB-5a55A:0.8","5aoxB-5a55A:6.31"],["5AOX_F_ACTF1001_0","ALU JO CONSENSUS RNA;SIGNAL RECOGNITION PARTICLE 14 KDA PROTEIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"TYR A 497;THR A 527;THR A 471","None","0.83A","5aoxE-5a55A:undetectable","5aoxE-5a55A:6.31"],["5ECL_A_ILEA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"VAL A 350;TYR A 353;VAL A 511;HIS A 545","None","1.01A","5eclA-5a55A:undetectable","5eclA-5a55A:19.59"],["5ESH_A_1YNA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"ALA A1081;LEU A1093;TYR A 873;GLY A1015;THR A1017","None","1.23A","5eshA-5a55A:undetectable","5eshA-5a55A:18.74"],["5ESM_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TYR A1266;PHE A1402;GLY A 730;LEU A 712","None","0.98A","5esmA-5a55A:undetectable","5esmA-5a55A:18.65"],["5F8Y_B_X6XB203_1","GALNAC\/GAL-SPECIFIC LECTIN","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"TYR A 652;GLY A 651;GLY A 656;HIS A 661;ASP A 658","None","1.46A","5f8yB-5a55A:undetectable","5f8yB-5a55A:8.97"],["5HQA_A_ACRA705_2","ALPHA-GLUCOSIDASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TRP A1380;PHE A1337;HIS A1352;THR A1257","None","1.40A","5hqaA-5a55A:9.1","5hqaA-5a55A:22.12"],["5HQA_A_ACRA705_2","ALPHA-GLUCOSIDASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TRP A1380;PHE A1337;HIS A1352;THR A1288","None","1.35A","5hqaA-5a55A:9.1","5hqaA-5a55A:22.12"],["5IWU_A_ERYA404_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"GLY A 619;ASP A 764;ILE A 693;TYR A 701","None","0.96A","5iwuA-5a55A:undetectable","5iwuA-5a55A:14.30"],["5JMN_A_FUAA1101_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"ILE A 786;ILE A 693;HIS A 694;VAL A 695","None","0.92A","5jmnA-5a55A:undetectable","5jmnA-5a55A:22.17"],["5M66_D_ADND502_2","ADENOSYLHOMOCYSTEINASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"THR A1257;THR A1301;LEU A1413","None","0.63A","5m66D-5a55A:undetectable","5m66D-5a55A:17.98"],["5NNW_D_GCSD302_1","25 KDA PROTEIN ELICITOR","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"GLY A 644;ASP A 970;HIS A 892;ASP A 608","None","0.95A","5nnwD-5a55A:undetectable","5nnwD-5a55A:5.91"],["5NO9_D_95ZD302_1","25 KDA PROTEIN ELICITOR","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"GLY A 644;ASP A 970;HIS A 892;ASP A 608","None","0.99A","5no9D-5a55A:undetectable","5no9D-5a55A:5.91"],["5OEX_A_CUA602_0","THIOCYANATE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"LYS A 650;HIS A 657;HIS A 694","None","1.16A","5oexA-5a55A:2.1","5oexA-5a55A:18.57"],["5OEX_B_CUB602_0","THIOCYANATE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"LYS A 650;HIS A 657;HIS A 694","None","1.15A","5oexB-5a55A:2.2","5oexB-5a55A:18.57"],["5OEX_C_CUC603_0","THIOCYANATE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"LYS A 650;HIS A 657;HIS A 694","None","1.15A","5oexC-5a55A:2.2","5oexC-5a55A:18.57"],["5OEX_D_CUD603_0","THIOCYANATE DEHYDROGENASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"LYS A 650;HIS A 657;HIS A 694","None","1.13A","5oexD-5a55A:2.5","5oexD-5a55A:18.57"],["5VLM_E_CVIE301_1","REGULATORY PROTEIN TETR","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"GLY A 842;TYR A 963;ASP A 884;ASP A 813","None","1.09A","5vlmE-5a55A:undetectable","5vlmE-5a55A:11.27"],["5XIQ_B_HFGB1002_0","PROLYL-TRNA SYNTHETASE (PRORS)","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"LEU A1297;PHE A1244;GLU A1350;HIS A1352;PHE A1318","None","1.41A","5xiqB-5a55A:undetectable","5xiqB-5a55A:18.12"],["5Y2T_A_8LXA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",3,"SER A 911;HIS A 477;TYR A 819","None","0.90A","5y2tA-5a55A:undetectable","5y2tA-5a55A:undetectable"],["6C71_B_NCTB501_1","AMINE OXIDASE","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"TYR A1158;GLU A1208;THR A1168;ASN A1177","None","1.21A","6c71B-5a55A:undetectable","6c71B-5a55A:5.68"],["6EBP_A_DAHA123_0","RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE, BETA SUBUNIT","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",5,"LEU A1195;THR A1194;ILE A1074;PHE A1206;ILE A1095","None","1.32A","6ebpA-5a55A:undetectable","6ebpA-5a55A:8.04"],["6FI4_B_DVAB8_0","14-3-3 PROTEIN SIGMA;PRO-SEP-LEU-PRO-DVA","5a55","ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE","Streptococcus pneumoniae",4,"SER A1103;VAL A1102;LYS A1101;ASN A1098","None","1.43A","6fi4A-5a55A:undetectable;6fi4B-5a55A:undetectable","6fi4A-5a55A:12.71;6fi4B-5a55A:0.86"]]